Completed × Adenocarcinoma Of Esophagus × Cisplatin × Clear all CHARIOT
Phase 1 Completed
36 enrolled 24 charts
Radiation Therapy and Chemotherapy Before and After Surgery in Treating Patients With Esophageal Cancer
Phase 2 Completed
97 enrolled 9 charts
Combination Chemotherapy After Surgery in Treating Patients With Cancer of the Esophagus or Stomach
Phase 2 Completed
55 enrolled
Combination Chemotherapy and Cetuximab in Treating Patients With Metastatic Esophageal Cancer or Gastroesophageal Junction Cancer
Phase 2 Completed
245 enrolled 15 charts
MATEO
Phase 2 Completed
242 enrolled
Surgery With or Without Combination Chemotherapy in Treating Patients With Cancer of the Esophagus
Phase 3 Completed
250 enrolled
Radiation Therapy and Chemotherapy, With or Without Cetuximab, Followed by Surgery in Treating Patients With Locally Advanced Esophageal Cancer That Can Be Removed by Surgery
Phase 3 Completed
297 enrolled
Chemotherapy and Radiation Therapy After Surgery in Treating Patients With Stomach or Esophageal Cancer
Phase 3 Completed
546 enrolled 11 charts
Surgery With or Without Radiation Therapy and Chemotherapy in Treating Patients With Esophageal Cancer
Phase 3 Completed
195 enrolled
Cisplatin, Irinotecan, and Radiation Therapy in Treating Patients With Esophageal Cancer or Gastroesophageal Junction Cancer That Can Be Removed By Surgery
Phase 2 Completed
82 enrolled 9 charts
Combination Chemotherapy Followed By Chemoradiotherapy, With or Without Surgery, in Treating Patients With Resectable Locally Advanced Cancer of the Esophagus or Gastroesophageal Junction
Phase 2 Completed
43 enrolled 5 charts
Surgery With or Without Chemotherapy and Radiation Therapy in Treating Patients With Cancer of the Esophagus
Phase 3 Completed
56 enrolled
Fluorouracil, Cisplatin, Cetuximab, and Radiation Therapy in Treating Patients With Esophageal Cancer That Can Be Removed by Surgery
Phase 1/2 Completed
33 enrolled
Irinotecan, Cisplatin, Bevacizumab, Radiation Therapy, and Surgery in Treating Patients With Locally Advanced Esophageal Cancer
Phase 2 Completed
34 enrolled 5 charts
Panitumumab, Docetaxel, Cisplatin, Radiation Therapy, and Surgery in Treating Patients With Newly Diagnosed, Locally Advanced Esophageal Cancer or Cancer of the Gastroesophageal Junction
Phase 2 Completed
70 enrolled 15 charts
Radiation Therapy + Combination Chemotherapy as 1st-Line Therapy for Patients With Inoperable Esophageal Cancer
Phase 2/3 Completed
266 enrolled
Cetuximab, Cisplatin, and Irinotecan in Treating Patients With Metastatic Esophageal Cancer, Gastroesophageal Junction Cancer, or Gastric Cancer That Did Not Respond to Previous Irinotecan and Cisplatin
Phase 2 Completed
16 enrolled 6 charts
Chemotherapy and Radiation Therapy With or Without Fluorouracil in Treating Patients With Cancer of the Stomach Who Have Undergone Surgery
Phase 2 Completed
Radiotherapy,Chemotherapy,Before and After Surgery in Advanced Esophageal or Gastroesophageal Junction Cancer
Phase 2 Completed
80 enrolled
Combination Chemotherapy, Radiation Therapy and Surgery for Esophageal Cancer
Phase 2 Completed
19 enrolled
Combination Chemotherapy Plus Radiation Therapy in Treating Patients With Esophageal Cancer
Phase 2 Completed
21 enrolled
Combination Chemotherapy Plus Radiation Therapy in Treating Patients With Cancer of the Esophagus
Phase 3 Completed
298 enrolled
3-AP Plus Cisplatin in Treating Patients With Recurrent or Metastatic Adenocarcinoma of the Esophagus or Gastroesophageal Junction
Phase 2 Completed
39 enrolled
Combination Chemotherapy Plus Radiation Therapy With or Without Fluorouracil in Treating Patients With Cancer of the Esophagus or Stomach
Phase 2 Completed
Combination Chemotherapy and Radiation Therapy in Treating Patients With Cancer of the Esophagus
Phase 1 Completed
24 enrolled
Combination Chemotherapy, Radiation Therapy and Surgery in Treating Patients With Cancer of the Esophagus
Phase 2 Completed
25 enrolled
Combination Chemotherapy Plus Radiation Therapy in Treating Patients With Esophageal Cancer
Phase 1 Completed
Combination Chemotherapy Followed by Surgery and Intraperitoneal Chemotherapy in Treating Patients With Locally Advanced Stomach Cancer
Phase 2 Completed
Combination Chemotherapy in Treating Patients With Locally Advanced or Metastatic Cancer of the Esophagus
Phase 2 Completed
Irinotecan, Radiation Therapy, and Docetaxel With or Without Cisplatin in Treating Patients With Locally Advanced Esophageal Cancer
Phase 1 Completed
27 enrolled
Cetuximab, Docetaxel, Cisplatin, and Radiation Therapy in Treating Patients With Locally Advanced Esophageal Cancer That Can Be Removed by Surgery
Phase 1/2 Completed
27 enrolled
Neoadjuvant Docetaxel and Cisplatin Plus Chemoradiotherapy Followed By Surgery in Treating Patients With Locally Advanced, Resectable Esophageal Cancer
Phase 2 Completed
66 enrolled
Docetaxel, Cisplatin, and Radiation Therapy in Treating Patients With Locally Advanced Esophageal Cancer That Cannot Be Removed By Surgery
Phase 2 Completed
21 enrolled
Combination Chemotherapy Plus Radiation Therapy in Treating Patients With Advanced or Metastatic Cancer of the Esophagus
Phase 1/2 Completed
26 enrolled
Irinotecan, Cisplatin, and Radiation Therapy With or Without Celecoxib in Treating Patients With Stage II, Stage III, or Stage IV Esophageal Cancer
Phase 2 Completed
14 enrolled
Doxorubicin, Cisplatin, 5-Fluorouracil in Patients With Advanced Adenocarcinoma of the Stomach or Esophagus
Phase 2 Completed
32 enrolled